Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

X-linked muscular dystrophy.

T Furukawa, J B Peter

    Annals of Neurology
    |November 1, 1977
    PubMed
    Summary
    This summary is machine-generated.

    X-linked muscular dystrophy presents with significant intrafamilial variability, challenging its classification into distinct benign and severe Duchenne types. These findings suggest a closer relationship between the different forms of this genetic muscle disorder.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The 'rule out lupus' rheumatology consultation: clinical outcomes and perspectives.

    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases·2008
    Same author

    Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus.

    Annals of the rheumatic diseases·2003
    Same author

    In vitro antiviral and antibacterial activity of commercial intravenous immunoglobulin preparations--a potential role for adjuvant intravenous immunoglobulin therapy in infectious diseases.

    Transfusion medicine (Oxford, England)·2002
    Same author

    Cytokine levels in various intravenous immunoglobulin (IVIg) preparations.

    Human antibodies·2001
    Same author

    Antiphospholipid antibody levels in intravenous immunoglobulin (IVIg) preparations.

    Lupus·2001
    Same author

    Are autoantibodies present in patients with subacute and chronic urticaria?

    Journal of investigational allergology & clinical immunology·2001
    Same journal

    Five Issues of Artificial Intelligence in Science: Sailing the Ship of Theseus.

    Annals of neurology·2026
    Same journal

    Reply to "Clinical Value of Aneurysm Wall Enhancement in Unruptured Intracranial Aneurysm".

    Annals of neurology·2026
    Same journal

    Clinical Value of Aneurysm Wall Enhancement in Unruptured Intracranial Aneurysm.

    Annals of neurology·2026
    Same journal

    Imaging of Neurovascular Compression in Thoracic Outlet Syndrome.

    Annals of neurology·2026
    Same journal

    Reply to "Methodological Challenges in Interpreting SAA-Defined Imaging Subgroups in Parkinson's Disease".

    Annals of neurology·2026
    Same journal

    Methodological Challenges in Interpreting SAA-Defined Imaging Subgroups in Parkinson's Disease.

    Annals of neurology·2026
    See all related articles

    Area of Science:

    • Genetics
    • Neuromuscular Disorders
    • Molecular Biology

    Background:

    • X-linked muscular dystrophy (XMD) is typically categorized into distinct benign and severe (Duchenne) forms.
    • Understanding the genetic basis of XMD heterogeneity is crucial for accurate diagnosis and prognosis.

    Observation:

    • Three families with XMD exhibited significant intrafamilial variability in disease severity.
    • Coexistence of both benign and severe XMD phenotypes within single families was observed.
    • Literature review confirmed families with coexisting benign and severe XMD types.

    Findings:

    • The study identified intrafamilial heterogeneity in X-linked muscular dystrophy, with both benign and severe Duchenne types present in affected families.
    • An "aggressive form" of XMD is proposed, exhibiting more severe symptoms than classic Duchenne dystrophy.

    Related Experiment Videos

  • Clinical similarities and familial coexistence suggest a strong relationship between benign and severe XMD forms.

    • Implications:

    • The findings challenge the strict separation of XMD into distinct entities.
    • Further research into the genetic determinants of XMD heterogeneity is warranted.
    • This study may lead to revised diagnostic criteria and therapeutic strategies for X-linked muscular dystrophy.